Literature DB >> 21055451

Neuropeptide Y-Y2 receptor knockout mice: influence of genetic background on anxiety-related behaviors.

E Zambello1, L Zanetti, G F Hédou, O Angelici, R Arban, R O Tasan, G Sperk, L Caberlotto.   

Abstract

Neuropeptide Y (NPY) has been extensively studied in relation to anxiety and depression but of the seven NPY receptors known to date, it is not yet clear which one is mainly involved in mediating its effects in emotional behavior. Mice lacking the NPY-Y2 receptors were previously shown to be less anxious due to their improved ability to cope with stressful situations. In the present study, the behavioral phenotype including the response to challenges was analyzed in NPY-Y2 knockout (KO) mice backcrossed in to congenic C57BL/6 background. In the elevated plus-maze (EPM) and the forced swim test (FST), the anxiolytic-like or antidepressant-like phenotype of the NPY-Y2 KO mice could not be confirmed, although this study differs from the previous one only with regard to the genetic background of the mice. In addition, no differences in response to acute stress or to the antidepressant desipramine in the FST were detected between wild type (WT) and NPY-Y2 KO animals. These results suggest that the genetic background of the animals appears to have a strong influence on the behavioral phenotype of NPY-Y2 KO mice. Additionally, to further characterize the animals by their biochemical response to a challenge, the neurochemical changes induced by the anxiogenic compound yohimbine were measured in the medial prefrontal cortex (mPFC) of NPY-Y2 KO and compared to WT mice. Dopamine (DA) levels were significantly increased by yohimbine in the WT but unaffected in the KO mice, suggesting that NPY-Y2 receptor exerts a direct control over both the tonic and phasic release of DA and that, although the anxiety-like behavior of these NPY-Y2 KO mice is unaltered, there are clear modifications of DA dynamics. However, yohimbine led to a significant increase in noradrenaline (NA) concentration and a slight reduction in serotonin concentration that were identical for both phenotypes.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21055451     DOI: 10.1016/j.neuroscience.2010.10.075

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Chronic stress alters neuropeptide Y signaling in the bed nucleus of the stria terminalis in DBA/2J but not C57BL/6J mice.

Authors:  Kristen E Pleil; Alberto Lopez; Nora McCall; Ana M Jijon; Jose Peña Bravo; Thomas L Kash
Journal:  Neuropharmacology       Date:  2011-12-09       Impact factor: 5.250

2.  Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.

Authors:  Haley L Yarosh; Jesus A Angulo
Journal:  Brain Res       Date:  2012-09-13       Impact factor: 3.252

3.  Lactation reduces stress-caused dopaminergic activity and enhances GABAergic activity in the rat medial prefrontal cortex.

Authors:  Virginia Arriaga-Avila; Eduardo Martínez-Abundis; Beatriz Cárdenas-Morales; Octavio Mercado-Gómez; Erick Aburto-Arciniega; Alfredo Miranda-Martínez; Keith M Kendrick; Rosalinda Guevara-Guzmán
Journal:  J Mol Neurosci       Date:  2013-10-02       Impact factor: 3.444

4.  The effects of ghrelin on energy balance and psychomotor activity in a goldfish model: an overview.

Authors:  Ki Sung Kang; Satowa Yahashi; Kouhei Matsuda
Journal:  Int J Pept       Date:  2011-05-24

5.  Effects of sex and deletion of neuropeptide Y2 receptors from GABAergic neurons on affective and alcohol drinking behaviors in mice.

Authors:  Nora M McCall; Gretchen M Sprow; Eric Delpire; Todd E Thiele; Thomas L Kash; Kristen E Pleil
Journal:  Front Integr Neurosci       Date:  2013-12-25

Review 6.  Neuropeptide Y: A stressful review.

Authors:  Florian Reichmann; Peter Holzer
Journal:  Neuropeptides       Date:  2015-09-30       Impact factor: 3.286

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.